CSIMarket



Dentsply Sirona Inc   (XRAY)
Other Ticker:  
 
 

XRAY's Revenue Growth by Quarter and Year

Dentsply Sirona Inc 's Revenue results by quarter and year




XRAY Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December 1,088.00 894.80 962.10 928.40
III Quarter September 1,069.00 490.60 1,009.40 1,042.10
II Quarter June 1,067.00 874.30 946.20 956.10
I Quarter March 1,027.00 1,111.50 1,059.70 1,129.50
FY   4,251.00 3,371.20 3,977.40 4,056.10



XRAY Revenue forth quarter 2021 Y/Y Growth Comment
Dentsply Sirona Inc achieved in the forth quarter 2021, above Company average Revenue growth of 21.59% year on year, to $ 1,088.00 millions.

Looking into forth quarter 2021 results within Medical Equipment & Supplies industry 31 other companies have achieved higher Revenue growth. While Dentsply Sirona Inc ' s Revenue rise of 21.59% ranks overall at the positon no. 964 in the forth quarter 2021.




XRAY Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December 21.59 % -7 % 3.63 % -8.01 %
III Quarter September 117.9 % -51.4 % -3.14 % 15.72 %
II Quarter June 22.04 % -7.6 % -1.04 % -4.05 %
I Quarter March -7.6 % 4.89 % -6.18 % 18.37 %
FY   26.1 % -15.24 % -1.94 % 5.07 %

Financial Statements
Dentsply Sirona Inc 's forth quarter 2021 Revenue $ 1,088.00 millions XRAY's Income Statement
Dentsply Sirona Inc 's forth quarter 2020 Revenue $ 894.80 millions Quarterly XRAY's Income Statement
New: More XRAY's historic Revenue Growth >>


XRAY Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December 1.78 % 82.39 % -4.69 % -10.91 %
III Quarter September 0.19 % -43.89 % 6.68 % 8.99 %
II Quarter June 3.89 % -21.34 % -10.71 % -15.35 %
I Quarter March 14.77 % 15.53 % 14.14 % 11.92 %
FY (Year on Year)   26.1 % -15.24 % -1.94 % 5.07 %




Revenue forth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #127
Overall #964

Revenue Y/Y Growth Statistics
High Average Low
74.48 % 2.68 % -13.11 %
(Dec 31 2013)   (Jun 30 2020)
Revenue forth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #127
Overall #964
Revenue Y/Y Growth Statistics
High Average Low
74.48 % 2.68 % -13.11 %
(Dec 31 2013)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Dentsply Sirona Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
82.39 % 2.13 % -43.89 %
(Sep 30 2020)  


XRAY's IV. Quarter Q/Q Revenue Comment
Dentsply Sirona Inc achieved in the IV. Quarter 2021 below company average Revenue growth of 1.78% quarter on quarter, to $ 1,088.00 millions.

Within Medical Equipment & Supplies industry 87 other companies have achieved higher Revenue quarter on quarter growth. While Dentsply Sirona Inc 's Revenue growth quarter on quarter, overall rank is 2222.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #88
Healthcare Sector #386
Overall #2222
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #88
Healthcare Sector #386
Overall #2222
Revenue Q/Q Growth Statistics
High Average Low
82.39 % 2.13 % -43.89 %
(Sep 30 2020)  


XRAY's IV. Quarter Q/Q Revenue Comment
Dentsply Sirona Inc achieved in the IV. Quarter 2021 below company average Revenue growth of 1.78% quarter on quarter, to $ 1,088.00 millions.

Within Medical Equipment & Supplies industry 87 other companies have achieved higher Revenue quarter on quarter growth. While Dentsply Sirona Inc 's Revenue growth quarter on quarter, overall rank is 2222.


Dentsply Sirona Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Sep 30 2020)
Cumulative Revenue 12 Months Ending $ 4,251.00 $ 4,057.80 $ 3,479.40 $ 3,286.70 $ 3,371.20
Y / Y Revenue Growth (TTM) 26.1 % 18.01 % -12.08 % -18.43 % -15.24 %
Year on Year Revenue Growth Overall Ranking # 729 # 1091 # 3078 # 1758 # 2511
Seqeuential Revenue Change (TTM) 4.76 % 16.62 % 5.86 % -2.51 % -1.96 %
Seq. Revenue Growth (TTM) Overall Ranking # 964 # 319 # 1807 # 2990 # 2498




Cumulative Revenue growth Comment
Dentsply Sirona Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 26.1% year on year, to $ 4,251 millions if the fiscal year would have ended in Dec 31 2021.
Dentsply Sirona Inc 's trailing twelve months Revenue growth was higher than company's average 15.67% and higher than 18.01% growth in Sep 30 2021.
But from the previous reporting period rise was less at 4.76 % from $4057.8 millions achieved in twelve months ending a quarter Sep 30 2021 Gracie Clark continued.
Still this was evidence of convincing trend, while the typical Q/Q TTM Revenue advancement lays at 2.68%.
The momentum is even stronger from the previous reporting period clinched at 4.76 % jump from $4057.8 millions in the period from Sep 30 2021 to Sep 30 2020.

In the Healthcare sector 100 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 729, from total ranking in previous quarter at 1091.

Revenue TTM Q/Q Growth Statistics
High Average Low
74.48 %
2.68 %
-13.11 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 32
Healthcare Sector # 101
Overall # 729

Revenue TTM Y/Y Growth Statistics
High Average Low
343.63 %
15.67 %
-18.43 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 32
Sector # 127
S&P 500 # 964
Cumulative Revenue growth Comment
Dentsply Sirona Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 26.1% year on year, to $ 4,251 millions if the fiscal year would have ended in Dec 31 2021.
Dentsply Sirona Inc 's trailing twelve months Revenue growth was higher than company's average 15.67% and higher than 18.01% growth in Sep 30 2021.
But from twelve months ended Sep 30 2021 rise was beneth at 4.76 % from $4057.8 millions reported in twelve months ending a quarter before Gracie Clark went on.
In spite of, it was validation of strength, while the average Q/Q TTM Revenue advancement is at 2.68%.
The momentum was even more impressive sequentially showed at 4.76 % increase from $4057.8 millions in twelve months ending a quarter before.

In the Healthcare sector 100 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 729, from total ranking in previous quarter at 1091.

Revenue TTM Q/Q Growth Statistics
High Average Low
74.48 %
2.68 %
-13.11 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 32
Healthcare Sector # 101
Overall # 729

Revenue TTM Y/Y Growth Statistics
High Average Low
343.63 %
15.67 %
-18.43 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 32
Sector # 127
S&P 500 # 964




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
XRAY's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for XRAY's Competitors
Revenue Growth for Dentsply Sirona Inc 's Suppliers
Revenue Growth for XRAY's Customers

You may also want to know
XRAY's Annual Growth Rates XRAY's Profitability Ratios XRAY's Asset Turnover Ratio XRAY's Dividend Growth
XRAY's Roe XRAY's Valuation Ratios XRAY's Financial Strength Ratios XRAY's Dividend Payout Ratio
XRAY's Roa XRAY's Inventory Turnover Ratio XRAY's Growth Rates XRAY's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2021
Optinose Inc 37.69%$ 37.695 millions
Lantheus Holdings Inc 37.61%$ 37.609 millions
Syros Pharmaceuticals inc 36.93%$ 36.925 millions
Horizon Therapeutics Public Limited Company36.11%$ 36.112 millions
Global Blood Therapeutics Inc 35.85%$ 35.849 millions
Insmed Inc35.52%$ 35.516 millions
Cyanotech Corp35.42%$ 35.419 millions
Caredx Inc 35.09%$ 35.086 millions
Strata Skin Sciences Inc 34.84%$ 34.837 millions
Arbutus Biopharma Corp34.37%$ 34.367 millions
Redhill Biopharma Ltd 33.25%$ 33.248 millions
Fortress Biotech Inc 32.93%$ 32.926 millions
Pacific Biosciences Of California Inc 32.28%$ 32.282 millions
Cutera Inc 31.41%$ 31.408 millions
Orthopediatrics Corp31.12%$ 31.119 millions
Vaso Corporation31.07%$ 31.065 millions
Establishment Labs Holdings Inc 30.97%$ 30.968 millions
Xoma Corporation30.97%$ 30.966 millions
Arrowhead Pharmaceuticals Inc 28.80%$ 28.803 millions
Sutro Biopharma Inc 28.70%$ 28.703 millions
Milestone Scientific Inc 28.66%$ 28.659 millions
Genetron Holdings Ltd28.31%$ 28.315 millions
Vertex Pharmaceuticals Inc27.32%$ 27.321 millions
Atricure Inc 26.84%$ 26.839 millions
Transmedics Group Inc 26.76%$ 26.760 millions
Imac Holdings Inc 26.14%$ 26.142 millions
Amphastar Pharmaceuticals Inc 26.03%$ 26.028 millions
West Pharmaceutical Services Inc 25.96%$ 25.957 millions
Adaptive Biotechnologies Corporation25.66%$ 25.658 millions
Invitae Corporation25.58%$ 25.580 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DGJI's Profile

Stock Price

DGJI's Financials

Business Description

Fundamentals

Charts & Quotes

DGJI's News

Suppliers

DGJI's Competitors

Customers & Markets

Economic Indicators

DGJI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071